Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652354
2.
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials.
Hepatology
; 79(1): 96-106, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37505216
3.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075781
4.
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.
Gut
; 73(1): 16-46, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37770126
5.
Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma.
Br J Cancer
; 128(9): 1672-1680, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813867
6.
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study.
Br J Cancer
; 128(10): 1922-1932, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959376
7.
Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy.
Br J Cancer
; 129(11): 1766-1772, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813958
8.
Immunobiology of cholangiocarcinoma.
J Hepatol
; 79(3): 867-875, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37201670
9.
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
J Hepatol
; 79(1): 93-108, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868481
10.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Future Oncol
; 19(34): 2277-2289, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746835
11.
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
Gut
; 71(8): 1669-1683, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580963
12.
Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.
Br J Cancer
; 126(5): 693-705, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663949
13.
Intrahepatic cholangiocarcinoma hidden within cancer of unknown primary.
Br J Cancer
; 127(3): 531-540, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484217
14.
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
J Hepatol
; 76(5): 1109-1121, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167909
15.
Biliary tract cancer.
Lancet
; 397(10272): 428-444, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516341
16.
Everolimus-Induced Pneumonitis in Patients with Neuroendocrine Neoplasms: Real-World Study on Risk Factors and Outcomes.
Oncologist
; 27(2): 97-103, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641203
17.
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System.
Hepatology
; 73(6): 2311-2325, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33073396
18.
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
Neuroendocrinology
; 112(3): 298-310, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940581
19.
Markers of tumor inflammation as prognostic factors for overall survival in patients with advanced pancreatic cancer receiving first-line FOLFIRINOX chemotherapy.
Acta Oncol
; 61(5): 583-590, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392758
20.
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 22(5): 690-701, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33798493